Companies /Healthcare

Compass Therapeutics Inc

NASDAQ: CMPX Biotechnology
$2.43
▼ $0.10 (−3.95%) today
Markets closed · 6:16pm ET
Today · % change

Fundamentals

Market Cap
$455.6M
EPS (TTM)
$-0.41
52-Week Range
$2 – $7
Street Target
$8.92

About Compass Therapeutics

Compass Therapeutics Inc is a biopharmaceutical company focused on creating innovative antibody therapies for cancer treatment. Based in Boston, Massachusetts, since 2014, it pioneers in developing drugs like CTX-009, CTX-471, and CTX-8371, targeting critical pathways and receptors involved in tumor growth and immune response. Their research aims to unlock new possibilities in oncology, offering hope for better, more effective treatments.

CMPX Coverage